Edition:
United States

People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

50.58USD
20 Oct 2017
Change (% chg)

$0.02 (+0.04%)
Prev Close
$50.56
Open
$50.54
Day's High
$50.84
Day's Low
$50.08
Volume
809,148
Avg. Vol
730,289
52-wk High
$63.40
52-wk Low
$42.75

Frates, James 

Mr. James M. Frates is Chief Financial Officer, Senior Vice President and Treasurer of Alkermes Plc. Prior to assuming his current positions, from May 2007 to September 16, 2011, Mr. Frates served as Senior Vice President and Chief Financial Officer of Alkermes, Inc. From June 1998 to May 2007, Mr. Frates served as Vice President, Chief Financial Officer and Treasurer of Alkermes, Inc. From June 1996 to June 1998, he was employed at Robertson, Stephens & Company, most recently as a Vice President in Investment Banking. Prior to that time he was employed at Morgan Stanley & Co. Mr. Frates serves on the board of directors of Sage Therapeutics, a publicly traded biotechnology company. Mr. Frates served on the board of directors of GPC Biotech AG, a biotechnology company, from June 2004 to 2009, and was a national director of the Association of Bioscience Financial Officers from 2004 to 2009. Mr. Frates is also a Trustee of St. Paul’s School and The Roxbury Latin School.

Basic Compensation

Total Annual Compensation, USD 499,741
Restricted Stock Awards, USD 580,860
Long-Term Incentive Plans, USD --
All Other, USD 1,597,460
Fiscal Year Total, USD 2,678,060

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

9,647,420

Shane Cooke

4,144,870

James Frates

2,678,060

Kathryn Biberstein

3,430,420

Elliot Ehrich

3,452,210

Iain Brown

--
As Of  30 Dec 2016